See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
05:01pm, Thursday, Aug 07, 2025
Vistagen Therapeutics Faces Rising Losses Amid Clinical Development Challenges and Growing Revenue
Company Overview Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company focused on developing non-systemic intranasal treatment options targeting CNS disorders via their proprietary pherine technology. The company's pipeline includes multiple product candida...
Read More